Boston Scientific Corp (BSX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2013 | 03-2013 | 12-2012 | 09-2012 | 06-2012 | |
| Sales | 1,809,000 | 1,761,000 | 1,820,000 | 1,735,000 | 1,828,000 |
| Cost of Goods | 530,000 | 578,000 | 582,000 | 558,000 | 578,000 |
| Gross Profit | 1,279,000 | 1,183,000 | 1,238,000 | 1,177,000 | 1,250,000 |
| Operating Expenses | 1,059,000 | 1,513,000 | 1,121,000 | 1,771,000 | 4,837,000 |
| Operating Income | 220,000 | -330,000 | 117,000 | -594,000 | -3,587,000 |
| Interest Expense | 65,000 | 65,000 | 63,000 | 65,000 | 64,000 |
| Other Income | -3,000 | 1,000 | -3,000 | -4,000 | 33,000 |
| Pre-tax Income | 152,000 | -394,000 | 51,000 | -663,000 | -3,618,000 |
| Income Tax | 22,000 | -40,000 | -10,000 | 1,000 | -40,000 |
| Net Income Continuous | 130,000 | -354,000 | 61,000 | -664,000 | -3,578,000 |
| Net Income | $130,000 | $-354,000 | $61,000 | $-664,000 | $-3,578,000 |
| EPS Basic Total Ops | 0.10 | -0.26 | 0.02 | -0.48 | -2.51 |
| EPS Basic Continuous Ops | 0.10 | -0.26 | 0.02 | -0.48 | -2.51 |
| EPS Diluted Total Ops | 0.10 | -0.26 | 0.02 | -0.48 | -2.51 |
| EPS Diluted Continuous Ops | 0.10 | -0.26 | 0.02 | -0.48 | -2.51 |
| EBITDA(a) | $220,000 | $-330,000 | $117,000 | $-594,000 | $-3,587,000 |